PR Newswire PharmaOriginal article
Okami Medical Receives Expanded Indication for the LOBO Vascular Occluder
RegulatoryapprovedLOBO Vascular Occlusion SystemPositive
AI Analysis
Summary
Okami Medical announced that the FDA has granted an expanded indication for its LOBO Vascular Occlusion System for vascular embolization applications. This regulatory approval expands the clinical utility of the company's novel vascular occlusion technology.
Outcome Details
FDA granted expanded indication for LOBO Vascular Occlusion System
Importance:7/10
Sentiment:
0.85
FDA approvalexpanded indicationvascular embolizationmedical device
Related Companies
Read the original article
Published by PR Newswire Pharma on October 7, 2026 9:51 PM